The globular domain treatment of adiponectin significantly increased endothelial nitric oxide synthase (eNOS) activity but decreased iNOS activity in hyperlipidemic vessels (37), which suggested that adiponectin protects the endothelium from hyperlipidemia through multiple mechanisms. This evidence concerns the gene ADIPOQ and hyperlipidemia.